Summary by Moomoo AI
Andrew Obenshain, President and CEO of bluebird bio, Inc., completed a sale of 3,162 shares of common stock on January 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $1.4294 each, resulting in a total sale value of approximately $4,519.76. Following the sale, Obenshain's direct holdings in the company amount to 287,972 shares of common stock.